![Stephen Mitchener](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Stephen Mitchener worked as the Head of US Oncology Strategy, Partnering & Operations at Novartis Pharmaceuticals Corp.
from 2005 to 2018.
He then worked as the Chief Business Officer at Karyopharm Therapeutics, Inc. before becoming the Chief Business Officer & Senior Vice President at Axcella Health, Inc. from 2018 to 2020.
Mitchener holds a doctorate degree from The University of North Carolina at Charlotte.
Anciens postes connus de Stephen Mitchener
| Sociétés | Poste | Fin |
|---|---|---|
| AXCA HEALPAR | Corporate Officer/Principal | 01/12/2020 |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Corporate Officer/Principal | 01/08/2018 |
| KARYOPHARM THERAPEUTICS INC. | Corporate Officer/Principal | - |
Formation de Stephen Mitchener
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
81
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
Karyopharm Therapeutics, Inc.
 Karyopharm Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel drugs for the treatment of cancer, inflammation and other diseases related to cell proliferation | Health Technology |
The University of North Carolina at Charlotte
 The University of North Carolina at Charlotte Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Axcella Health, Inc.
 Axcella Health, Inc. BiotechnologyHealth Technology Provides first-in-class precision therapeutic solutions to diseases with a focus on restoring amino acid biology | Health Technology |
